BioNTech, Coinbase Global, Pharming Group And Other Big Stocks Moving Lower On Monday

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Monday. Here are some big stocks recording losses in today’s session.

Near Intelligence, Inc. NIR shares tumbled 25.5% to $9.07.
Pharming Group N.V. PHAR dipped 18.9% to $12.31. The FDA approved Pharming Group’s Joenja (leniolisib) for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) in adult and pediatric patients 12 years of age and older.
YS Biopharma Co., Ltd. YS fell 10.6% to $4.2819 after the company reported interim Phase 2 safety and immunogenicity data for its PIKA recombinant Covid-19 vaccine.
ARS Pharmaceuticals, Inc. SPRY dropped 10.5% to $6.79. ARS Pharmaceuticals recently posted a FY22 loss of $0.87 per share.
Ribbon Communications Inc. RBBN declined 10% to $3.3750.
Vigil Neuroscience, Inc. VIGL fell 9.8% to $11.01. Morgan Stanley maintained Vigil Neuroscience with an Equal-Weight and raised the price target from $12 to $13.
Frontier Communications Parent, Inc. FYBR declined 9.1% to $21.42. Frontier partnered with YouTube TV to deliver internet & tv experience. Morgan Stanley downgraded Frontier Communications from Equal-Weight to Underweight and lowered the price target from $23 to $19.
Cipher Mining Inc. CIFR fell 8.4% to $1.96.
Loop Media, Inc. LPTV dropped 8.3% to $5.03.
PepGen Inc. PEPG dipped 8.1% to $14.00. PopGen recently reported Q4 and full year 2022 financial results.
Manchester United plc MANU fell 7.7% to $22.09. Manchester United received a fresh overnight bid from Qatari Sheikh Jassim Bin Hamad Al Thani, who had requested a deadline extension on Wednesday, according to Sky News.
Innoviz Technologies Ltd. INVZ dropped 6.6% to $3.18.
Coinbase Global, Inc. COIN fell 6.6% to $63.32 after Barclays maintained an Equal-Weight rating on the stock and lowered its price target from $86 to $70.
Youdao, Inc. DAO fell 6.3% to $8.05.
Aldeyra Therapeutics, Inc. ALDX dropped 5.7% to $8.52.
BioNTech SE BNTX fell 4.1% to $122.89 after the company said Q4 EPS and sales results were lower year over year.